Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego - PIB.
Opportunity Score
Confidence: 40%
Complexity: high
17 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This tender by the Military Institute of Medicine (Wojskowy Instytut Medyczny - PIB) in Poland is for the supply of medicinal products and medical devices, divided into 92 lots (packages). Each lot covers different therapeutic categories such as antineoplastic agents, painkillers, and other pharmaceuticals. The contract durations range from 12 to 39 months. Award is based solely on price (100% weight). No estimated value is provided. Submission is electronic via the platform, with Polish as the required language. The tender includes option rights for quantity and duration adjustments.
Strengths
Documents available
Open procedure
17 days left
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Submission via electronic platform only (Open portal).
- Tenders must be in Polish language.
- Maximum 92 lots can be bid.
Buyer
Name
Wojskowy Instytut Medyczny - Państwowy Instytut Badawczy
Location
Warszawa, POL
Website
Identifier
Numer KRS: 0000144810
Lots (92)
Dostawa produktu leczniczego Lutetium (177Lu) oxodotreotidi - 360 sztuk.
Dostawa różnych produktów leczniczych - 71 pozycji.
Dostawa środków przeciwbólowych - 3 pozycje.
Procurement Details
Publication
19 May 2026
Deadline
02 Jul 2026, 08:00
Procedure
open
Contract
supplies
Duration
21 MONTH
Language
POL
Publication #
343464-2026
Classification
Performance: Poland
Documents (2)
Opportunity Score
Confidence: 40%
Complexity: high
17 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation